Results 81 to 90 of about 1,308,546 (203)

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update)

open access: yesMycoses, Volume 69, Issue 9, September 2026.
ABSTRACT Background Central nervous system (CNS) aspergillosis is a life‐threatening infection with mortality rates exceeding 50%, especially in immunocompromised patients. Significant challenges persist due to limited antifungal drug penetration into the CNS, emerging resistance, and diagnostic delays, despite advancements in therapy and diagnostics ...
Moustafa A. Mansour   +5 more
wiley   +1 more source

Invasive pulmonary aspergillosis presenting as thoracic mass causing obstruction of the superior and inferior vena cava in an immunocompetent patient: a diagnostic dilemma

open access: yesAnnals of Saudi Medicine, 2015
Invasive pulmonary aspergillosis (IPA) is a disease of immunocompromised patients, but its prevalence is increasing in immunocompetent persons. Patients usually present with non-specific symptoms, sometimes consistent with bronchopneumonia.
Moti lal Bunkar   +2 more
doaj   +1 more source

Granulomatous response to invasive pulmonary aspergillosis in an immunotherapy-naive host, a maladaptive response?

open access: yesRespiratory Medicine Case Reports, 2018
Pulmonary aspergillosis causes a wide spectrum of disease, ranging from asymptomatic airway colonization to severe invasive disease, contingent on the host's immune status and underlying pulmonary anatomy.
Andres L. Mora Carpio   +4 more
doaj   +1 more source

Pulmonary Aspergillosis: An Observation from a Tertiary Care Hospital of Western Uttar Pradesh

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth
Background: Aspergillus is the most frequently occurring fungal infection in immunocompromised patients with a high mortality rate. Invasive pulmonary aspergillosis is the most serious entity on the spectrum of pulmonary aspergillosis. Limited studies on
Zeba Naj, Peetam Singh, Anita Pandey
doaj   +1 more source

Treatment Of Invasive Aspergillosis [PDF]

open access: yes, 2018
Invasive aspergillosis (IA) is an infectious disease caused by Aspergillus species, is usually seen in patients with immune deficiency and has been associated with high mortality rate.
Mustafa DOĞAN   +4 more
core  

[Invasive pulmonary aspergillosis: possibility of radiologic diagnosis]

open access: yes, 1992
The incidence of invasive pulmonary aspergillosis is increasing in the patients with malignant hematologic diseases; this occurs in the phase of granulocytopenia induced by chemotherapy.
TODESCHINI, Giuseppe   +6 more
core   +1 more source

Pulmonary Aspergillosis: A Review on Diagnosis and Management [PDF]

open access: yes, 2018
Aspergillosis is acquired by inhalation of spores of Aspergillus, a ubiquitous species in the environment. In normal hosts, spore inhalation rarely causes lung disease. Pulmonary aspergillosis covers a wide spectrum of clinical syndromes depending on the
Saad, Mohamed   +5 more
core   +1 more source

Aspergillus spondylodiscitis in a patient with liver cirrhosis and diabetes mellitus

open access: yesZdravniški Vestnik, 2014
Aspergillus osteomyelitis is a rare manifestation of invasive aspergillosis which accounts for 1.8% to 5.6% of all invasive aspergillosis forms. As other forms of invasive aspergillosis, it predominantly occurs in immunosupressed patients with well ...
Tereza Rojko   +4 more
doaj  

Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report

open access: yesJournal of Infection and Public Health, 2018
We present the case of an 8-year-old immunocompromised boy with invasive pulmonary aspergillosis, complicated with pleural empyema and disseminated to the bone and central nervous system (CNS).
Alanoud Almuhareb, Zakaria Habib
doaj   +1 more source

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

open access: yes, 2015
Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary disease, complicating many other respiratory disorders, thought to affect ¡"240000 people in Europe.
Ader, F.   +43 more
core   +1 more source

Home - About - Disclaimer - Privacy